Lifevantage (NASDAQ: LFVN) reported Q2 EPS of $0.22, $0.08 better than the analyst estimate of $0.14. Revenue for the quarter came in at $67.8 million versus the consensus estimate of $51.9 million.

GUIDANCE:

Lifevantage sees FY2025 EPS of $0.72-$0.88, versus the consensus of $0.76. Lifevantage sees FY2025 revenue of $235-245 million, versus the consensus of $238.49 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.